Search

everythinglearnresearchcommunity

for

Search:↓

Training programs are needed to improve home COVID-19 management and educate on vital sign monitoring and danger signs.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

Certain immune responses may cause ongoing COVID-19 symptoms like fatigue and brain fog.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

The pandemic worsened physical and mental challenges for women with PCOS.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Most people in South India lack knowledge about managing COVID-19 at home.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Old age, male sex, smoking, and obesity may affect COVID-19 severity, but more research is needed.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

COVID-19 infection may trigger alopecia areata in some patients.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 may cause temporary hair loss in some people.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

COVID-19 survivors may face long-term health issues affecting both mind and body.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Possible link between androgens and COVID-19 severity; more research needed.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.